Transmedics Group Inc (NASDAQ:TMDX) price on Thursday, January 16, fall -4.00% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $58.02.
A look at the stock’s price movement, the close in the last trading session was $60.44, moving within a range at $57.9 and $60.775. The beta value (5-Year monthly) was 2.071 while the PE ratio in trailing twelve months stood at 62.16. Turning to its 52-week performance, $177.37 and $58.27 were the 52-week high and 52-week low respectively. Overall, TMDX moved -9.71% over the past month.
Transmedics Group Inc’s market cap currently stands at around $1.95 billion, with investors looking forward to this quarter’s earnings report slated for in February.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TMDX is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
7 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 2 analyst(s) rate the stock as a Hold, 5 recommend TMDX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TMDX’s current price about -10.53% and -20.69% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 36.51, while 7-day volatility ratio is 9.81% and 6.62% in the 30-day chart. Further, Transmedics Group Inc (TMDX) has a beta value of 2.11, and an average true range (ATR) of 5.43. Analysts have given the company’s stock an average 52-week price target of $109, forecast between a low of $90 and high of $125. Looking at the price targets, the low is -55.12% off current price level while to achieve the yearly target high, price needs to move -115.44%. Nonetheless, investors will most likely welcome a -87.87% jump to $109 which is the analysts’ median price.
If we refocus on Transmedics Group Inc (NASDAQ:TMDX), historical trading data shows that trading volumes averaged 3.8 over the past 10 days and 2.22 million over the past 3 months. The company’s latest data on shares outstanding shows there are 33.56 million shares.
The 3.39% of Transmedics Group Inc’s shares are in the hands of company insiders while institutional holders own 109.81% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 9.15 million on 2024-12-31, giving us a short ratio of 5.42. The data shows that as of 2024-12-31 short interest in Transmedics Group Inc (TMDX) stood at 3316.9997000000003 of shares outstanding, with shares short falling to 9.29 million registered in 2024-11-29. Current price change has pushed the stock -6.94% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TMDX stock continues to rise going into the next quarter.
